MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Camps, P.
Right arrow Articles by Rosenberry, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camps, P.
Right arrow Articles by Rosenberry, T. L.

Vol. 57, Issue 2, 409-417, February 2000

Huprine X is a Novel High-Affinity Inhibitor of Acetylcholinesterase That Is of Interest for Treatment of Alzheimer's Disease

Pelayo Camps, Bernadette Cusack, William D. Mallender, Rachid El Achab, Jordi Morral, Diego Muñoz-Torrero, and Terrone L. Rosenberry

Department of Pharmacology, Mayo Foundation for Medical Education and Research and the Department of Research, Mayo Clinic Jacksonville, Jacksonville, Florida (B.C., W.D.M., T.L.R.); and Laboratori de Química Farmacèutica, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain (P.C., R.E.A., J.M., D.M.-T.).

Inhibitors of the enzyme acetylcholinesterase (AChE) slow and sometimes reverse the cognitive decline experienced by individuals with Alzheimer's disease. Huperzine A, a natural product used in traditional Chinese herbal medicine, and tacrine (Cognex) are among the potent AChE inhibitors used in this treatment, but the search for more selective inhibitors continues. We report herein the synthesis and characterization of (-)-12-amino-3-chloro-9-ethyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline hydrochloride (huprine X), a hybrid that combines the carbobicyclic substructure of huperzine A with the 4-aminoquinoline substructure of tacrine. Huprine X inhibited human AChE with an inhibition constant KI of 26 pM, indicating that it binds to this enzyme with one of the highest affinities yet reported. Under equivalent assay conditions, this affinity was 180 times that of huperzine A, 1200 times that of tacrine, and 40 times that of E2020 (donepezil, Aricept), the most selective AChE inhibitor currently approved for therapeutic use. The association and dissociation rate constants for huprine X with AChE were determined, and the location of its binding site on the enzyme was probed in competition studies with the peripheral site inhibitor propidium and the acylation site inhibitor edrophonium. Huprine X showed no detectable affinity for the edrophonium-AChE complex. In contrast, huprine X did form a ternary complex with propidium and AChE, although its affinity for the free enzyme was found to be 17 times its affinity for the propidium-AChE complex. These data indicated that huprine X binds to the enzyme acylation site in the active site gorge but interferes slightly with the binding of peripheral site ligands.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. J. Thomas, Z. Shen, J. E. Crowell, M. G. Finn, and G. Siuzdak
Desorption/ionization on silicon (DIOS): A diverse mass spectrometry platform for protein characterization
PNAS, April 5, 2001; (2001) 81069298.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Z. Radic' and P. Taylor
Interaction Kinetics of Reversible Inhibitors and Substrates with Acetylcholinesterase and Its Fasciculin 2 Complex
J. Biol. Chem., February 9, 2001; 276(7): 4622 - 4633.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. V. De Ferrari, W. D. Mallender, N. C. Inestrosa, and T. L. Rosenberry
Thioflavin T Is a Fluorescent Probe of the Acetylcholinesterase Peripheral Site That Reveals Conformational Interactions between the Peripheral and Acylation Sites
J. Biol. Chem., June 22, 2001; 276(26): 23282 - 23287.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. J. Thomas, Z. Shen, J. E. Crowell, M. G. Finn, and G. Siuzdak
Desorption/ionization on silicon (DIOS): A diverse mass spectrometry platform for protein characterization
PNAS, April 24, 2001; 98(9): 4932 - 4937.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics